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First identified in 1982 as a human pathogen, enterohemorrhagic Escherichia coli of the O157:H7 serotype is a major cause of
food-borne acquired human infections. Here, we report the genome sequence of the first known strain of this serotype isolated
in the United States.
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Since the initial report in 1982 that Escherichia coli O157:H7 isassociated with severe human disease, the serotype O157:H7
has assumed a position of dominance among enterohemorrhagic
E. coli (EHEC) serotypes in North America responsible for global
widespread outbreaks of severe gastrointestinal disease (1, 2). This
lineage of Shiga toxin-producing E. coli (STEC) O157:H7 is
non-sorbitol fermenting and -glucuronidase negative and has
evolved from an O55:H7 progenitor (3, 4). The isolation in 1975
of this E. coli O157:H7 strain, designated 2886-75, from an adult
with hemorrhagic colitis (HC) (5, 6) predated the 1982 Oregon
and Michigan hamburger-associated E. coli O157:H7 outbreaks
(6). Since 1982, this serogroup has emerged as the dominant cause
of EHEC infections in North America. Infections typically present
with symptoms of bloody diarrhea coupled with severe abdominal
pain (5, 6) but can rapidly progress to life-threatening complica-
tions, such as hemolytic uremic syndrome (HUS), HC, and cen-
tral nervous system failure (7–12).
Genomic DNA was subjected to Illumina sequencing using
paired-end libraries with 300-bp inserts on the HiSeq platform.
The draft genome was assembled with Velvet assembler (13, 14),
and the IGS Annotation Engine and Manatee were used for ge-
nome annotation and visualization (15). Availability of the
high-quality genome sequence enabled the determination of the
pathogenome virulence state (16) and phylogenomic grouping
according to established genotypic classification methods using
in-silico and experimental assays (17–20). PCR genotyping con-
firmed the stx genotype and determined the occupancy of both the
yehV and wrbA bacteriophage insertion sites (21). Strain 2886-75
has an unusual genotype. Unlike the majority of E. coli O157:H7
recovered from humans in the United States (22–24), this isolate is
stx1 positive and stx2 negative. The yehV site is occupied by the stx1
bacteriophage that is not stably integrated. Hence, the genomic
architecture does not fit the emergence scenario typical of other
human-pathogenicE. coliO157:H7 strains, and this isolate cannot
be placed into clusters 1, 2, or 3 (25). However, this strain shows
other typical genetic hallmarks of EHEC. Strain 2886-75 carries
the lineage-specific virulence plasmid pO157 (26, 27), the T allele
of the translocated intimin receptor (tir) (255 TA), and a chi-
meric polymorphic variant of repeat region 1 (RR1) with the ab-
sence of the repeat regions RR2 and RR3, placing strain 2886-75
closest to group 8 (28). Multilocus sequence typing (MLST) (18)
based on the nucleotide sequences of 15 housekeeping genes re-
vealed that 2886-75 exhibits allele combination 23.11 (19) and
belongs to the sequence type 11 (ST11) and complex/ABD group
(18, 20). Strain 2886-75 is a representative of lineage I (17, 29) and
clade 3.16 (30). The genome sequence presented here will be a
valuable resource in studying E. coli O157:H7 pathogenome evo-
lution by comparing this isolate to the extant genotypes and will
aid in the development of a higher-resolution phylogenomic
framework for improved molecular-guided pathogen surveillance
and outbreak investigations (10, 11, 31).
Nucleotide sequence accession number. This genome se-
quence is deposited in GenBank under the accession number
AVRR00000000. A bacterial strain culture is available from the
Biodefense and Emerging Infections Research Resources Reposi-
tory (http://www.beiresources.org/).
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